Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | TSPO | P30536 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18540682 | 0.95 | TSPO (0.44) | CASP3TSHRMAPTNOTUMTSPO | |
| SCHEMBL21636110 | 0.86 | ALDH1A1 (0.47) | CASP3MAPTALDH1A1LMNAL3MBTL1 | |
| SCHEMBL28393607 | 0.85 | MAPT (0.42) | TSHRMAPTTSPOALDH1A1LMNA | |
| SCHEMBL27120040 | 0.85 | TSHR (0.41) | CASP3TSHRNOTUMTSPOALDH1A1 | |
| SCHEMBL30159243 | 0.84 | TSPO (0.41) | CASP3TSHRMAPTTSPOALDH1A1 | |
| SCHEMBL11926711 | 0.84 | JAK2 (0.38) | CASP3TSHRMAPTTSPOALDH1A1 | |
| SCHEMBL1832121 | 0.81 | DNMT1 (0.41) | MAPTTSPOALDH1A1DNM1SMN1; SMN2 | |
| SCHEMBL2951637 | 0.80 | MAPT (0.41) | CASP3MAPTTSPOALDH1A1LMNA | |
| SCHEMBL19269510 | 0.79 | ACHE (0.40) | TSHRMAPTTSPOALDH1A1LMNA | |
| SCHEMBL26529691 | 0.79 | SMN1; SMN2 (0.39) | MAPTNOTUMTSPOHCAR1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-7732065-B2 | Anthracene derivative compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-06-08 | — | — | US | disclosed |
| US-20080111478-A1 | ANTHRACENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-15 | — | — | US | disclosed |
| US-20070009761-A1 | Hole transport material for organic electroluminescence devices and organic electroluminescence device using the same | SANYO ELECTRIC CO., LTD. | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080111478-A1 | ANTHRACENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AR, CYP1A1, ARL1 | CASP3 2574/4885TSHR 3785/4885MAPT 2624/4885 |
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | CASP3 4540/4885TSHR 4810/4885MAPT 742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.